Galactokinase Activity




Test Mnemonic

GALK

CPT Codes

  • 82759 - QTY (1)

Aliases

  • Galactokinase (RBC)
  • Galactokinase Deficiency
  • Galactosemia

Performing Laboratory

Mayo Clinic Dpt of Lab Med & Pathology


Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
4 mLWhole bloodEDTA (Lavender) Refrigerated 

Alternate Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
4 mLWhole bloodSodium or Lithium heparin (Green) Refrigerated 
4 mLWhole bloodACD A (Yellow) Refrigerated 

Minimum Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
2 mL     

Stability

Environmental Condition Description
Refrigerated10 days
Ambient72 hours
FrozenUnacceptable

Days Performed

Mon

Turnaround Time

9 - 16 days

Methodology

Name Description
Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) 
Enzyme Reaction 

Reference Range

Galactokinase
Sex Age From Age To Type Range Range Unit
       >=0.7 nmol/h/mg Hgb 

Special Info

Specimen CANNOT be frozen. Specimen must arrive at performing lab within 48 hours of collection. New York State approved.

Clinical Info

Useful for diagnosis of galactokinase deficiency. Galactokinase (GALK) deficiency is the second most common form of galactosemia, affecting approximately 1/250,000 live births, with a higher frequency in the Romani population. Individuals with GALK deficiency have a milder clinical presentation than that seen in patients with classic galactosemia, galactose-1-phosphate uridyltransferase (GALT) deficiency. The major clinical manifestation is bilateral juvenile cataracts. GALK deficiency is treated with a lactose-restricted diet. Early treatment may prevent or reverse the formation of cataracts. In GALK deficiency, erythrocyte galactose-1-phosphate levels are generally normal and plasma galactose levels are generally elevated. The diagnosis is established by demonstrating deficient GALK enzyme activity in erythrocytes. Testing for GALK deficiency should be performed when there is a suspicion of galactosemia, either based upon the patient's clinical presentation or laboratory studies and GALT deficiency has been excluded. Specimens sent for GALT analysis may be used for GALK testing if the original specimen was received in the laboratory within 48 hours of draw. GALK deficiency is caused by mutations in the GALK1 gene. Gene analysis is available from some commercial laboratories. Cautions: It is important to notify the laboratory if the patient has been transfused prior to specimen collection. The results of testing performed in erythrocytes are invalid following a transfusion, including analysis of enzymes, biochemical phenotyping, or galactose-1-phosphate.